Literature DB >> 323143

Evaluation of serum opsonic capacity by quantitating the initial chemiluminescent response from phagocytizing polymorphonuclear leukocytes.

R C Allen.   

Abstract

Phagocytically activated polymorphonuclear leukocytes produced a chemiluminescence that could be correlated metabolically with the stimulated oxidation of glucose via the hexose monophosphate shunt, The chemiluminescence observed was considered to originate from the relaxation of electronically excited carbonyl groups produced during singlet molecular oxygen-mediated microbicidal oxidation of the ingested microbe. With adequate adjustment of leukocyte and bacterial concentrations, the rate of chemiluminescence increase was nearly constant for the first minutes after initiation of phagocytosis. This rate was dependent on the quantity of bacteria phagocytized by the leukocytes. If both leukocytes and bacterial concentrations were held constant, this initial rate of chemiluminescence reflected the opsonic capacity of the sera used for opsonization. The prior absorption of opsonins from serum resulted in a decresed rate of chemiluminescence related to the quantity of bacteria used for absorption. Heating of sera to 56 degrees C for 30 min resulted in a great decrease in the chemiluminescent responses and may reflect the role of complement in the opsonization process.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 323143      PMCID: PMC421447          DOI: 10.1128/iai.15.3.828-833.1977

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  20 in total

1.  Myeloperoxidase of the leucocyte of normal human blood. I. Content and localization.

Authors:  J SCHULTZ; K KAMINKER
Journal:  Arch Biochem Biophys       Date:  1962-03       Impact factor: 4.013

2.  The biochemical basis of phagocytosis. 2. Incorporation of C14-labeled building blocks into lipid, protein, and glycogen of leukocytes during phagocytosis.

Authors:  A J SBARRA; M L KARNOVSKY
Journal:  J Biol Chem       Date:  1960-08       Impact factor: 5.157

3.  Role of the superoxide anion in the myeloperoxidase-mediated antimicrobial system.

Authors:  S J Klebanoff
Journal:  J Biol Chem       Date:  1974-06-25       Impact factor: 5.157

4.  Defective superoxide production by granulocytes from patients with chronic granulomatous disease.

Authors:  J T Curnutte; D M Whitten; B M Babior
Journal:  N Engl J Med       Date:  1974-03-14       Impact factor: 91.245

5.  Biological defense mechanisms. The production by leukocytes of superoxide, a potential bactericidal agent.

Authors:  B M Babior; R S Kipnes; J T Curnutte
Journal:  J Clin Invest       Date:  1973-03       Impact factor: 14.808

6.  Chloramines as intermediates of oxidation reaction of amino acids by myeloperoxidase.

Authors:  J M Zgliczyński; T Stelmaszyńska; J Domański; W Ostrowski
Journal:  Biochim Biophys Acta       Date:  1971-06-16

7.  Direct involvement of NADPH oxidase with the stimulated respiratory and hexose monophosphate shunt activities in phagocytizing leukocytes.

Authors:  B B Paul; R R Strauss; A A Jacobs; A J Sbarra
Journal:  Exp Cell Res       Date:  1972-08       Impact factor: 3.905

Review 8.  Mechanism of phagocytosis-associated oxidative metabolism in polymorphonuclear leucocytes and macrophages.

Authors:  F Rossi; D Romeo; P Patriarca
Journal:  J Reticuloendothel Soc       Date:  1972-08

9.  Role of singlet oxygen in some chemiluminescence and enzyme oxidation reactions.

Authors:  R Nilsson; D R Kearns
Journal:  J Phys Chem       Date:  1974-08-15

10.  The superoxide anion and singlet molecular oxygen: their role in the microbicidal activity of the polymorphonuclear leukocyte.

Authors:  R C Allen; S J Yevich; R W Orth; R H Steele
Journal:  Biochem Biophys Res Commun       Date:  1974-10-08       Impact factor: 3.575

View more
  31 in total

1.  Chemiluminescence of human and canine polymorphonuclear leukocytes in the absence of phagocytosis.

Authors:  L Harvath; H J Amirault; B R Andersen
Journal:  J Clin Invest       Date:  1978-05       Impact factor: 14.808

2.  In vitro evaluation of opsonic and cellular granulocyte function by luminol-dependent chemiluminescence: utility in patients with severe neutropenia and cellular deficiency states.

Authors:  P Stevens; D J Winston; K Van Dyke
Journal:  Infect Immun       Date:  1978-10       Impact factor: 3.441

3.  Functional capacity of immunoglobulin G preparations and the F(ab')2 split product.

Authors:  R W Steele; R W Steele
Journal:  J Clin Microbiol       Date:  1989-04       Impact factor: 5.948

4.  Chemiluminescence by polymorphonuclear leukocytes adhering to surfaces.

Authors:  M Yanai; P G Quie
Journal:  Infect Immun       Date:  1981-06       Impact factor: 3.441

5.  Adhesion of piliated Escherichia coli strains to phagocytes: differences between bacteria with mannose-sensitive pili and those with mannose-resistant pili.

Authors:  E Blumenstock; K Jann
Journal:  Infect Immun       Date:  1982-01       Impact factor: 3.441

6.  Assessment of the efficacy of polyclonal intravenous immunoglobulin G (IVIG) against the infectivity of clinical isolates of methicillin-resistant Staphylococcus aureus (MRSA) in vitro and in vivo.

Authors:  N Farag; L Mahran; K Abou-Aisha; M El-Azizi
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2013-03-27       Impact factor: 3.267

Review 7.  Poly-L-arginine and an N-formylated chemotactic peptide act synergistically with lectins and calcium ionophore to induce intense chemiluminescence and superoxide production in human blood leukocytes. Modulation by metabolic inhibitors, sugars, and polyelectrolytes.

Authors:  I Ginsburg; R Borinski; M Lahav; Y Matzner; I Eliasson; P Christensen; D Malamud
Journal:  Inflammation       Date:  1984-03       Impact factor: 4.092

8.  The influence of killed Mycobacterium leprae and other mycobacteria on opsonized yeast phagocytosis.

Authors:  I A Cree; J S Beck
Journal:  Clin Exp Immunol       Date:  1986-04       Impact factor: 4.330

9.  Assessment of Haemophilus influenzae type b opsonins by neutrophil chemiluminescence.

Authors:  S L Kaplan; C L Umstead; E O Mason; D C Anderson; J C Parke; R D Feigin
Journal:  J Clin Microbiol       Date:  1981-03       Impact factor: 5.948

10.  The onset of polymorphonuclear leucocyte membrane-stimulated metabolic activity.

Authors:  A J Williams; P J Cole
Journal:  Immunology       Date:  1981-08       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.